Daniel Comiskey to Humans
This is a "connection" page, showing publications Daniel Comiskey has written about Humans.
Connection Strength
0.155
-
Comiskey DF, He H, Liyanarachchi S, Sheikh MS, Hendrickson IV, Yu L, Brock PL, de la Chapelle A. Characterizing the function of EPB41L4A in the predisposition to papillary thyroid carcinoma. Sci Rep. 2020 11 17; 10(1):19984.
Score: 0.026
-
Comiskey DF, He H, Liyanarachchi S, Sheikh MS, Genutis LK, Hendrickson IV, Yu L, Brock PL, de la Chapelle A. Variants in LRRC34 reveal distinct mechanisms for predisposition to papillary thyroid carcinoma. J Med Genet. 2020 08; 57(8):519-527.
Score: 0.025
-
Comiskey DF, Montes M, Khurshid S, Singh RK, Chandler DS. SRSF2 Regulation of MDM2 Reveals Splicing as a Therapeutic Vulnerability of the p53 Pathway. Mol Cancer Res. 2020 02; 18(2):194-203.
Score: 0.025
-
Comiskey DF, Jacob AG, Singh RK, Tapia-Santos AS, Chandler DS. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage. Nucleic Acids Res. 2015 Apr 30; 43(8):4202-18.
Score: 0.018
-
Brock P, Sevigny M, Liyanarachchi S, Comiskey DF, Li W, Saarinen S, Yilmaz AS, Nieminen AI, Ringel MD, Peltom?ki P, Ollila S, Nieminen TT. PDPR Gene Variants Predisposing to Papillary Thyroid Cancer. Thyroid. 2024 05; 34(5):575-582.
Score: 0.008
-
He H, Liyanarachchi S, Li W, Comiskey DF, Yan P, Bundschuh R, Turkoglu AM, Brock P, Ringel MD, de la Chapelle A. Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma. Sci Rep. 2021 07 08; 11(1):14126.
Score: 0.007
-
Nieminen TT, Liyanarachchi S, Comiskey DF, Wang Y, Li W, Hendrickson IV, Brock P, de la Chapelle A, He H. A novel essential splice site variant in SPTB in a large hereditary spherocytosis family. Mol Genet Genomic Med. 2021 05; 9(5):e1641.
Score: 0.007
-
Truong T, Lesueur F, Sugier PE, Guibon J, Xhaard C, Karimi M, Kulkarni O, Lucotte EA, Bacq-Daian D, Boland-Auge A, Mulot C, Laurent-Puig P, Schvartz C, Guizard AV, Ren Y, Adjadj E, Rach?di F, Borson-Chazot F, Ortiz RM, Lence-Anta JJ, Pereda CM, Comiskey DF, He H, Liyanarachchi S, de la Chapelle A, Elisei R, Gemignani F, Thomsen H, Forsti A, Herzig AF, Leutenegger AL, Rubino C, Ostroumova E, Kesminiene A, Boutron-Ruault MC, Deleuze JF, Gu?nel P, de Vathaire F. Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium. Int J Cancer. 2021 06 15; 148(12):2935-2946.
Score: 0.007
-
He H, Li W, Comiskey DF, Liyanarachchi S, Nieminen TT, Wang Y, DeLap KE, Brock P, de la Chapelle A. A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres. Thyroid. 2020 02; 30(2):204-213.
Score: 0.006
-
Wang Y, Liyanarachchi S, Miller KE, Nieminen TT, Comiskey DF, Li W, Brock P, Symer DE, Akagi K, DeLap KE, He H, Koboldt DC, de la Chapelle A. Identification of Rare Variants Predisposing to Thyroid Cancer. Thyroid. 2019 07; 29(7):946-955.
Score: 0.006
-
Jendrzejewski JP, Sworczak K, Comiskey DF, de la Chapelle A. Clinical implications of GWAS variants associated with differentiated thyroid cancer. Endokrynol Pol. 2019; 70(5):423-429.
Score: 0.006
-
Montes M, Sanford BL, Comiskey DF, Chandler DS. RNA Splicing and Disease: Animal Models to Therapies. Trends Genet. 2019 01; 35(1):68-87.
Score: 0.006
-
Jacob AG, Singh RK, Comiskey DF, Rouhier MF, Mohammad F, Bebee TW, Chandler DS. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways. PLoS One. 2014; 9(8):e104444.
Score: 0.004
-
Jacob AG, O'Brien D, Singh RK, Comiskey DF, Littleton RM, Mohammad F, Gladman JT, Widmann MC, Jeyaraj SC, Bolinger C, Anderson JR, Barkauskas DA, Boris-Lawrie K, Chandler DS. Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma. Neoplasia. 2013 Sep; 15(9):1049-63.
Score: 0.004